LBC
MRK icon

Leigh Baldwin & Co’s Merck MRK Stock Holding History

Leigh Baldwin & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$695K Sell
5,407
-157
-3% -$18.4K 0.37% 63
2026
Q1 		$669K Sell
5,564
-4
-0.1% -$462 0.43% 52
2025
Q4 		$586K Sell
5,568
-16,618
-75% -$1.56M 0.39% 62
2025
Q3 		$1.86M Buy
22,186
+805
+4% +$66.3K 1.05% 21
2025
Q2 		$1.69M Buy
21,381
+319
+2% +$25.4K 1.11% 19
2025
Q1 		$1.89M Sell
21,062
-353
-2% -$33K 1.52% 16
2024
Q4 		$2.13M Buy
+21,415
New +$2.21M 1.8% 11

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Leigh Baldwin & Co's MRK Position: Q2 2026 in Review

Leigh Baldwin & Co reduced its Merck (MRK) stake by 2.8% in Q2 2026, selling an estimated $18.4K and leaving 5,407 shares worth $695K. The position accounts for 0.37% of the portfolio, ranked #63.

Leigh Baldwin & Co first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.13M in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Leigh Baldwin & Co held 5,407 shares of Merck worth $695K as of Q2 2026.
  • Leigh Baldwin & Co sold 157 Merck shares in Q2 2026, an estimated $18.4K.
  • Merck made up 0.37% of Leigh Baldwin & Co's portfolio in Q2 2026, its #63 holding.
  • Leigh Baldwin & Co first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Leigh Baldwin & Co's Merck position peaked at $2.13M in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Leigh Baldwin & Co's 13F filing for Q2 2026, filed 13 Aug 2026.